medigraphic.com
ISSN 1028-4796 (Impreso)

2013, Número 1

<< Anterior Siguiente >>

Rev Cubana Plant Med 2013; 18 (1)


Actividad antiinflamatoria, antioxidante y antibacteriana de dos especies del género Tabebuia

Franco OLA, Castro GJP, Ocampo BYC, Pájaro BIB, Díaz CF

Idioma: Español
Referencias bibliográficas: 48
Paginas: 34-46
Archivo PDF: 153.27 Kb.


RESUMEN

Introducción: Tabebuia rosea (Bertol.) A. DC. y Tabebuia ochracea (Cham.) Standl., que pertenecen a la familia Bignoniaceae, son utilizadas en la medicina popular por su potencial farmacológico como antiinflamatorio y antibacteriano, lo que ha motivado su estudio químico y biológico.
Objetivos: determinar la actividad antiinflamatoria, antioxidante y antibacteriana de extractos totales etanólicos y fracciones en éter, diclorometano, acetato de etilo y etanol, obtenidas a partir de la corteza interna de Tabebuia rosea y Tabebuia ochracea.
Métodos: el material vegetal se extrajo por maceración con etanol y se fraccionó mediante procedimientos de partición líquido/líquido. La actividad antiinflamatoria se evaluó utilizando el modelo murino in vivo de edema auricular inducido por 13-acetato de 12-orto-tetradecanoilforbol, mientras que la actividad antioxidante y antibacteriana se determinó in vitro, utilizando el método de captación del radical 2,2-difenil-1-picrilhidrazilo y métodos de difusión en agar, respectivamente.
Resultados: los extractos etanólicos de la corteza de Tabebuia rosea y Tabebuia ochracea, así como algunas de sus fracciones, mostraron significativa actividad antiinflamatoria y antioxidante; en términos generales Tabebuia rosea resultó más activa como antiinflamatoria, mientras que en cuanto a la actividad antioxidante Tabebuia ochracea mostró ser más potente. Ambas especies de Tabebuia presentaron importante actividad antibacteriana frente a Staphylococcus aureus ATCC25923.
Conclusiones: se demostró actividad antiinflamatoria, captadora de radicales libres 2,2-difenil-1-picrilhidrazilo y antibacteriana, en extractos totales y fracciones obtenidas de Tabebuia rosea y Tabebuia ochracea. Este constituye el primer reporte que valida el uso popular dado a estas especies como antiinflamatorio y antibacteriano, en la costa norte colombiana.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bayarsaihan D. Epigenetic mechanisms in inflammation. J Dent Res. 2011;90(1):9-17.

  2. Hutchinson JL, Rajagopal SP, Sales KJ, Jabbour HN. Molecular regulators of resolution of inflammation: potential therapeutic targets in the reproductive system. Reproduction. 2011;142(1):15-28.

  3. Chow JM, Shen SC, Huan SK, Lin HY, Chen YC. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochemical pharmacology. 2005;69(12):1839-51.

  4. Cui XY, Kim JH, Zhao X, Chen BQ, Lee BC, Pyo HB, et al. Antioxidative and acute anti-inflammatory effects of Campsis grandiflora flower. J Ethnopharmacol. 2006;103(2):223-8.

  5. Naik E, Dixit VM. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med. 2011;208(3):417-20.

  6. Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007;7(2):161-7.

  7. Fayon M. CF-Emerging therapies: Modulation inflammation. Paediatr Respir Rev. 2006;7 Suppl 1:S170-4.

  8. Heijerman H. Infection and inflammation in cystic fibrosis: a short review. J Cyst Fibros. 2005;4 Suppl 2:3-5.

  9. Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, et al. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Pediatr. 2009;154(2):183-8.

  10. Chen HH, Liu X, Ni C, Lu YP, Xiong GY, Lu YY, et al. Bacterial biofilms in chronic rhinosinusitis and their relationship with inflammation severity. Auris Nasus Larynx. 2012;39(2):169-74.

  11. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000;109(4):288-95.

  12. Omabe M, Ezeani M. Infection, inflammation and prostate carcinogenesis. Infect Genet Evol. 2011;11(6):1195-8.

  13. Steenkamp V, Gouws MC, Gulumian M, Elgorashi EE, van Staden J. Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis. J Ethnopharmacol. 2006;103(1):71-5.

  14. Weidner W, Anderson RU. Evaluation of acute and chronic bacterial prostatitis and diagnostic management of chronic prostatitis/chronic pelvic pain syndrome with special reference to infection/inflammation. Int J Antimicrob Agents. 2008;31 Suppl 1:S91-5.

  15. Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41(12):844-9.

  16. D'Aiuto F, Parkar M, Brett PM, Ready D, Tonetti MS. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine. 2004;28(1):29-34.

  17. Robinson K, Argent RH, Atherton JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21(2):237-59.

  18. Justiniano JFT, Nash D. Ecología y silvicultura de especies menos conocidas Tajibos o Lapachos Tabebuia spp. Gomes ex A.P. de Candolle Bignoniaceae. Bolivia: Editora El País; 2000. p. 60.

  19. Maistro EL, Fernandes DM, Pereira FM, Andrade SF. Lapachol induces clastogenic effects in rats. Plant med. 2010;76(9):858-62.

  20. Hofling JF, Anibal PC, Obando-Pereda GA, Peixoto IA, Furletti VF, Foglio MA, et al. Antimicrobial potential of some plant extracts against Candida species. Braz J Biol. 2010;70(4):1065-8.

  21. Menna-Barreto RF, Henriques-Pons A, Pinto AV, Morgado-Diaz JA, Soares MJ, De Castro SL. Effect of a beta-lapachone-derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles. J Antimicrob Chemother. 2005;56(6):1034-41.

  22. Higa RA, Aydos RD, Silva IS, Ramalho RT, Souza AS. Study of the antineoplastic action of Tabebuia avellanedae in carcinogenesis induced by azoxymethane in mice. Acta Cir Bras. 2011;26(2):125-8.

  23. de Miranda FG, Vilar JC, Alves IA, Cavalcanti SC, Antoniolli AR. Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract. BMC Pharmacol. 2001;1:6.

  24. Pereira EM, Machado Tde B, Leal IC, Jesus DM, Damaso CR, Pinto AV, et al. Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis. Ann Clin Microbiol Antimicrob. 2006;5:5.

  25. Park BS, Kim JR, Lee SE, Kim KS, Takeoka GR, Ahn YJ, et al. Selective growth-inhibiting effects of compounds identified in Tabebuia impetiginosa inner bark on human intestinal bacteria. J Agric Food Chem. 2005;53(4):1152-7.

  26. Park BS, Lee HK, Lee SE, Piao XL, Takeoka GR, Wong RY, et al. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. J Ethnopharmacol. 2006;105(1-2):255-62.

  27. Byeon SE, Chung JY, Lee YG, Kim BH, Kim KH, Cho JY. In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae. J Ethnopharmacol. 2008;119(1):145-52.

  28. Joabe Gomes M, Ariane Gaspar S, Elba L, Ulysses Paulino A. Medicinal plants used as antitumor agents in Brazil: an ethnobotanical approach. Evidence-Based Complementary and Alternative Medicine. 2011;ID(365359):1-14.

  29. De Young LM, Kheifets JB, Ballaron SJ, Young JM. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions. 1989;26(3-4):335-41.

  30. Payá M, Ferrándiz ML, Sanz MJ, Bustos G, Blasco R, Rios JL, et al. Study of the antioedema activity of some seaweed and sponge extracts from the mediterranean coast in mice. Phytotherapy Research. 1993;7(2):159-62.

  31. Franco LA, Matiz GE, Calle J, Pinzón R, Ospina LF. Antiinflammatory activity of extracts and fractions obtained from Physalis peruviana L. calyces]. Biomedica: revista del Instituto Nacional de Salud. 2007;27(1):110.

  32. Silva BM, Andrade PB, Valentao P, Ferreres F, Seabra RM, Ferreira MA. Quince (Cydonia oblonga Miller) fruit (pulp, peel, and seed) and Jam: antioxidant activity. J Agric Food Chem. 2004;52(15):4705-12.

  33. Santos AKL, Costa JGM, Menezes IRA, Cansanção IF, Santos KKA, Matias EFF, et al. Antioxidant activity of five Brazilian plants used as traditional medicines and food in Brazil. Pharmacognosy magazine. 2010;6(24):335.

  34. Mitscher LA, Leu RP, Bathala MS, Wu WN, Beal JL. Antimicrobial agents from higher plants. I. Introduction, rationale, and methodology. Lloydia. 1972;35(2):157-66.

  35. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45(4):493-6.

  36. Xian YF, Mao QQ, Ip SP, Lin ZX, Che CT. Comparison on the Anti-inflammatory Effect of Cortex Phellodendri Chinensis and Cortex Phellodendri Amurensis in 12-O-tetradecanoylphorbol-acetate-induced ear edema in mice. Journal of Ethnopharmacology. 2011;137(3):1425-30.

  37. Al-Reza SM, Yoon JI, Kim HJ, Kim JS, Kang SC. Anti-inflammatory activity of seed essential oil from Zizyphus jujuba. Food and Chemical Toxicology. 2010;48(2):639-43.

  38. Koyama J, Morita I, Tagahara K, Hirai K. Cyclopentene dialdehydes from Tabebuia impetiginosa. Phytochemistry. 2000;53(8):869-72.

  39. Ospina Giraldo LF, Aragón DM, Vergel NE, Isaza G, Pérez JE. Anti-inflammatory and antioxidant activities of Phenax rugosus (poir.) Wedd and Tabebuia chrysanta g. Nicholson. Vitae. 2011;18(1):49-55.

  40. Vaidya AD, Vaidya R. Reactive oxygen species, anti-oxidant enzymes and smoldering chronic inflammation: Relevance to diabetes mellitus, atherosclerosis, and menopausal metabolic syndrome. J Midlife Health. 2011;2(2):49-50.

  41. Velazco E, Nieves B, Araque M, Calderas Z. Epidemiología de infecciones nosocomiales por Staphylococcus aureus en una unidad de alto riesgo neonatal. Enferm Infecc Microbiol Clin. 2002;20(7):321-5.

  42. Mendoza Ticona CA, Velasquez Talavera R, Mercado Diaz L. Susceptibilidad antimicrobiana de Staphylococcus aureus sensible, con sensibilidad» BORDERLINE» y resistentes a la meticilina. Rev Med Hered. 2003;14(4):181-5.

  43. Bamberger DM, Boyd SE. Management of Staphylococcus aureus infections. American family physician. 2005;72(12):2474.

  44. Díaz F, Medina JD. Furanonaphthoquinones from Tabebuia ochracea ssp. neochrysanta. Journal of natural products. 1996;59(4):423-4.

  45. Girard M, Kindack D, Dawson BA, Ethier JC, Awang DVC, Gentry AH. Naphthoquinone constituents of Tabebuia spp. Journal of natural products. 1988;51(5):1023-4.

  46. Riffel A, Medina L, Stefani V, Santos R, Bizani D, Brandelli A. In vitro antimicrobial activity of a new series of 1, 4-naphthoquinones. Brazilian journal of medical and biological research. 2002;35(7):811-8.

  47. Sathiya M, Muthuchelian K. Studies on Phytochemical Profile and Antibacterial Activity of Ethanolic Leaf Extract of Tabebuia rosea (Bertol.) DC. Ethnobotanical Leaflets. 2008;12(1):1153-57.

  48. Binutu OA, Lajubutu BA. Antimicrobial potentials of some plant species of the Bignoniaceae family. African journal of medicine and medical sciences. 1994;23(3):269-73.




2020     |     www.medigraphic.com